$HCSG
HEALTHCARE SERVICES GROUP INC

2020 Q2 Form 10-Q Financial Statement

#000073101220000066 Filed on July 24, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $452.0M $462.1M
YoY Change -2.18% -7.87%
Cost Of Revenue $387.5M $400.5M
YoY Change -3.24% -8.21%
Gross Profit $64.51M $61.62M
YoY Change 4.7% -5.64%
Gross Profit Margin 14.27% 13.33%
Selling, General & Admin $41.47M $38.61M
YoY Change 7.4% 13.16%
% of Gross Profit 64.27% 62.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.600M $2.300M
YoY Change 13.04% 76.92%
% of Gross Profit 4.03% 3.73%
Operating Expenses $41.47M $38.61M
YoY Change 7.4% 13.16%
Operating Profit $23.05M $23.01M
YoY Change 0.17% -26.22%
Interest Expense -$380.0K -$783.0K
YoY Change -51.47% 10.13%
% of Operating Profit -1.65% -3.4%
Other Income/Expense, Net
YoY Change
Pretax Income $30.41M $23.62M
YoY Change 28.77% -29.11%
Income Tax $7.311M $5.431M
% Of Pretax Income 24.04% 23.0%
Net Earnings $23.10M $18.19M
YoY Change 27.03% -29.55%
Net Earnings / Revenue 5.11% 3.94%
Basic Earnings Per Share $0.31 $0.24
Diluted Earnings Per Share $0.31 $0.24
COMMON SHARES
Basic Shares Outstanding 74.70M shares 74.35M shares
Diluted Shares Outstanding 74.76M shares 74.62M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.4M $95.70M
YoY Change 78.06% 8.63%
Cash & Equivalents $78.11M $16.16M
Short-Term Investments $92.30M $79.50M
Other Short-Term Assets $24.20M $26.60M
YoY Change -9.02% -3.62%
Inventory $33.70M $40.00M
Prepaid Expenses $24.18M $26.57M
Receivables $295.3M $346.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $523.5M $509.0M
YoY Change 2.86% 1.64%
LONG-TERM ASSETS
Property, Plant & Equipment $28.60M $29.60M
YoY Change -3.39% 123.35%
Goodwill $51.08M $51.08M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $71.40M $0.00
YoY Change -100.0%
Total Long-Term Assets $213.1M $201.1M
YoY Change 5.98% 18.25%
TOTAL ASSETS
Total Short-Term Assets $523.5M $509.0M
Total Long-Term Assets $213.1M $201.1M
Total Assets $736.7M $710.1M
YoY Change 3.74% 5.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.37M $59.29M
YoY Change 0.13% -14.41%
Accrued Expenses $89.20M $62.10M
YoY Change 43.64% 13.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.00M
YoY Change -100.0% -25.93%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $169.5M $151.4M
YoY Change 11.96% -7.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $117.5M $109.1M
YoY Change 7.7% 10.87%
Total Long-Term Liabilities $117.5M $109.1M
YoY Change 7.7% 10.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $169.5M $151.4M
Total Long-Term Liabilities $117.5M $109.1M
Total Liabilities $287.0M $260.5M
YoY Change 10.17% -0.84%
SHAREHOLDERS EQUITY
Retained Earnings $176.3M $188.0M
YoY Change -6.25% 16.59%
Common Stock $278.2M $268.6M
YoY Change 3.59% 4.66%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.862M $9.350M
YoY Change -5.22% -2.37%
Treasury Stock Shares 1.311M shares 1.407M shares
Shareholders Equity $449.7M $449.6M
YoY Change
Total Liabilities & Shareholders Equity $736.7M $710.1M
YoY Change 3.74% 5.85%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $23.10M $18.19M
YoY Change 27.03% -29.55%
Depreciation, Depletion And Amortization $2.600M $2.300M
YoY Change 13.04% 76.92%
Cash From Operating Activities $79.70M $2.700M
YoY Change 2851.85% -22.86%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$1.200M
YoY Change -16.67% -7.69%
Acquisitions
YoY Change
Other Investing Activities -$100.0K -$300.0K
YoY Change -66.67% -50.0%
Cash From Investing Activities -$1.100M -$1.500M
YoY Change -26.67% -16.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -65.00M -13.50M
YoY Change 381.48% -1450.0%
NET CHANGE
Cash From Operating Activities 79.70M 2.700M
Cash From Investing Activities -1.100M -1.500M
Cash From Financing Activities -65.00M -13.50M
Net Change In Cash 13.60M -12.30M
YoY Change -210.57% -555.56%
FREE CASH FLOW
Cash From Operating Activities $79.70M $2.700M
Capital Expenditures -$1.000M -$1.200M
Free Cash Flow $80.70M $3.900M
YoY Change 1969.23% -18.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000731012
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-12015
dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE SERVICES GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2018365
dei Entity Address Address Line1
EntityAddressAddressLine1
3220 Tillman Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Bensalem
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19020
dei City Area Code
CityAreaCode
215
dei Local Phone Number
LocalPhoneNumber
639-4274
dei Trading Symbol
TradingSymbol
HCSG
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74423000 shares
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78109000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27329000 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
92318000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
90711000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74882000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45726000 USD
CY2020Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
295261000 USD
CY2019Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
340930000 USD
CY2020Q2 us-gaap Other Inventory
OtherInventory
33677000 USD
CY2019Q4 us-gaap Other Inventory
OtherInventory
36517000 USD
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24176000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20245000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
523541000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
515732000 USD
CY2020Q2 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
28558000 USD
CY2019Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
28820000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
51084000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
51084000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21383000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19300000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20270000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22353000 USD
CY2020Q2 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
9104000 USD
CY2019Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
6667000 USD
CY2020Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
41868000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
46992000 USD
CY2020Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
37217000 USD
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
37247000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
34150000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
20364000 USD
CY2020Q2 us-gaap Assets
Assets
736688000 USD
CY2019Q4 us-gaap Assets
Assets
722592000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
59369000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54418000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50494000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36413000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13904000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16489000 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
10000000 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
20922000 USD
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75732000 shares
CY2020Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
24806000 USD
CY2019Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
23256000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
169495000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8075000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
148651000 USD
CY2020Q2 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
68212000 USD
CY2019Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
64366000 USD
CY2020Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
37211000 USD
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
37621000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12083000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11649000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75557000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74421000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74149000 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
757000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
756000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
277482000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
270614000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
176268000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
195455000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4042000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2919000 USD
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1311000 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1408000 shares
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8862000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9439000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
449687000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
460305000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
736688000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
722592000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
452029000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
462101000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
901179000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
938212000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
387517000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
400485000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
774673000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
827750000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41465000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38609000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71482000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79710000 USD
CY2020Q2 hcsg Investment Income And Other
InvestmentIncomeAndOther
7745000 USD
CY2019Q2 hcsg Investment Income And Other
InvestmentIncomeAndOther
1393000 USD
hcsg Investment Income And Other
InvestmentIncomeAndOther
2918000 USD
hcsg Investment Income And Other
InvestmentIncomeAndOther
6596000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-380000 USD
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-783000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-748000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1839000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
30412000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23617000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
57194000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
35509000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7311000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5431000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13903000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8167000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
23101000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
18186000 USD
us-gaap Net Income Loss
NetIncomeLoss
43291000 USD
us-gaap Net Income Loss
NetIncomeLoss
27342000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74695000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74352000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74676000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74327000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74761000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74619000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74764000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74669000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
23101000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
18186000 USD
us-gaap Net Income Loss
NetIncomeLoss
43291000 USD
us-gaap Net Income Loss
NetIncomeLoss
27342000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1656000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
791000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1123000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2207000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24757000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18977000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44414000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29549000 USD
us-gaap Net Income Loss
NetIncomeLoss
43291000 USD
us-gaap Net Income Loss
NetIncomeLoss
27342000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7146000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6997000 USD
hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
5921000 USD
hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
21465000 USD
hcsg Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans
DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans
-3923000 USD
hcsg Deferred Income Tax Expense Benefit Excluding Tax Benefit From Equity Compensation Plans
DeferredIncomeTaxExpenseBenefitExcludingTaxBenefitFromEquityCompensationPlans
-18000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3925000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3659000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
950000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
712000 USD
hcsg Unrealized Gain Loss On Securities Related To Deferred Compensation Fund
UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund
961000 USD
hcsg Unrealized Gain Loss On Securities Related To Deferred Compensation Fund
UnrealizedGainLossOnSecuritiesRelatedToDeferredCompensationFund
5041000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-2635000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
25305000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2840000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1305000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3931000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2847000 USD
hcsg Increase Decrease In Deferred Compensation Funding
IncreaseDecreaseInDeferredCompensationFunding
-990000 USD
hcsg Increase Decrease In Deferred Compensation Funding
IncreaseDecreaseInDeferredCompensationFunding
-89000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-964000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-8824000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
16104000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-2678000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
12847000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7140000 USD
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
5396000 USD
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
5423000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
117000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
5200000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
92383000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20339000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
307000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
87000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1835000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2496000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6939000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8234000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5779000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
7145000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2688000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3498000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
30161000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29276000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
45000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1862000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3099000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
10000000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
661000 USD
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
579000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38915000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26710000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50780000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9869000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27329000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26025000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78109000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16156000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
460305000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20190000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-533000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19657000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1724000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
661000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1822000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
528000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1835000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15142000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
23000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
187000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
438179000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
23101000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1656000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24757000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
138000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1830000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
-2000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15237000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
22000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
449687000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
440780000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
9156000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1416000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10572000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1913000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
579000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1656000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
536000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2130000 USD
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14656000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
23000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
174000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
442549000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
18186000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
791000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18977000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1186000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1668000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
-2000 USD
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14753000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
23000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
449648000 USD
hcsg Revenue From Contract With Customer Renewal Term
RevenueFromContractWithCustomerRenewalTerm
P1Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Use Of Estimates
UseOfEstimates
In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.
CY2019Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
340930000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
46992000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45726000 USD
CY2019Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
6667000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
20364000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
195455000 USD
hcsg Period Of Amortization Of Inventories And Supplies
PeriodOfAmortizationOfInventoriesAndSupplies
P24M
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.205
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At June 30, 2020 and December 31, 2019, substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.</span></div>
CY2020Q2 hcsg Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities
ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities
1 financial_institution
CY2019Q4 hcsg Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities
ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities
1 financial_institution
hcsg Revenue From Contract With Customer Renewal Term
RevenueFromContractWithCustomerRenewalTerm
P1Y
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.At June 30, 2020, the Company had $559.4 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 20.5% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consists of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.
hcsg Revenue From Contract With Customer Renewal Term
RevenueFromContractWithCustomerRenewalTerm
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
559400000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q2 hcsg Accounts Notes Loansand Financing Receivable Gross Current
AccountsNotesLoansandFinancingReceivableGrossCurrent
370143000 USD
CY2019Q4 hcsg Accounts Notes Loansand Financing Receivable Gross Current
AccountsNotesLoansandFinancingReceivableGrossCurrent
386656000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74882000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45726000 USD
CY2020Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
295261000 USD
CY2019Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
340930000 USD
CY2020Q2 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
50972000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
53659000 USD
CY2020Q2 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
9104000 USD
CY2019Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
6667000 USD
CY2020Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
41868000 USD
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
46992000 USD
CY2020Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
337129000 USD
CY2019Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
387922000 USD
CY2020Q2 hcsg Financing Receivable Interest Income
FinancingReceivableInterestIncome
400000 USD
hcsg Financing Receivable Interest Income
FinancingReceivableInterestIncome
1000000.0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff Year One Originated Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearOneOriginatedCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
411000 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
1721000 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
36000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2168000 USD
hcsg Financing Receivable Allowance For Credit Loss Recovery Year One Originated Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearOneOriginatedCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Recovery Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Recovery Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Recovery Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Recovery Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Recovery Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossRecoveryOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
0 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year One Originated Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearOneOriginatedCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
411000 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
0 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
1721000 USD
hcsg Financing Receivable Allowance For Credit Loss Writeoff After Recovery Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
36000 USD
us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
2168000 USD
CY2020Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
11777000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
74389000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
9987000 USD
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1897000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
66299000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17891000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2168000 USD
CY2020Q2 us-gaap Financing Receivable Change In Present Value Expense Reversal
FinancingReceivableChangeInPresentValueExpenseReversal
1964000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17687000 USD
CY2020Q1 hcsg Accounts Receivable And Financing Receivable Allowance For Credit Loss
AccountsReceivableAndFinancingReceivableAllowanceForCreditLoss
92280000 USD
CY2020Q2 hcsg Accounts And Financing Receivable Allowance For Credit Loss Writeoff
AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff
12155000 USD
CY2020Q2 hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
3861000 USD
CY2020Q2 hcsg Accounts Receivable And Financing Receivable Allowance For Credit Loss
AccountsReceivableAndFinancingReceivableAllowanceForCreditLoss
83986000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
800000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
39903000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
14396000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4083000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
66299000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12490000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2168000 USD
us-gaap Financing Receivable Change In Present Value Expense Reversal
FinancingReceivableChangeInPresentValueExpenseReversal
1838000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17687000 USD
CY2019Q4 hcsg Accounts Receivable And Financing Receivable Allowance For Credit Loss
AccountsReceivableAndFinancingReceivableAllowanceForCreditLoss
52393000 USD
hcsg Accounts And Financing Receivable Allowance For Credit Loss Writeoff
AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff
16564000 USD
hcsg Accounts And Financing Receivable Credit Loss Expense Reversal
AccountsAndFinancingReceivableCreditLossExpenseReversal
5921000 USD
CY2020Q2 hcsg Accounts Receivable And Financing Receivable Allowance For Credit Loss
AccountsReceivableAndFinancingReceivableAllowanceForCreditLoss
83986000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
800000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
1057000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
2286000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-66000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
79000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1123000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2207000 USD
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
100000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
100000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
300000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
600000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24449000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21176000 USD
CY2020Q2 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
57900000 USD
CY2019Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
60862000 USD
CY2020Q2 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
29342000 USD
CY2019Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
32042000 USD
CY2020Q2 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
28558000 USD
CY2019Q4 hcsg Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
28820000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
2600000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
2300000 USD
us-gaap Depreciation
Depreciation
5100000 USD
us-gaap Depreciation
Depreciation
4800000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1400000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2700000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1000000.0 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2200000 USD
hcsg Lessee Operating Lease Termination Option Term
LesseeOperatingLeaseTerminationOptionTerm
P1Y
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1394000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1016000 USD
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
124000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
340000 USD
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
116000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
131000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
1634000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
1487000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
2749000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
2230000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
253000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
561000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
262000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
284000 USD
us-gaap Lease Cost
LeaseCost
3264000 USD
us-gaap Lease Cost
LeaseCost
3075000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2793000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2702000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M24D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2019Q2 hcsg Operating Lease Rightof Use Asset Cancellation
OperatingLeaseRightofUseAssetCancellation
100000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2019Q2 hcsg Operating Lease Liability Cancellation
OperatingLeaseLiabilityCancellation
100000 USD
hcsg Operating Lease Liability Cancellation
OperatingLeaseLiabilityCancellation
300000 USD
hcsg Operating Lease Rightof Use Asset Cancellation
OperatingLeaseRightofUseAssetCancellation
300000 USD
CY2019Q2 hcsg Operating Lease Liability Cancellation
OperatingLeaseLiabilityCancellation
100000 USD
CY2019Q2 hcsg Operating Lease Rightof Use Asset Cancellation
OperatingLeaseRightofUseAssetCancellation
100000 USD
hcsg Operating Lease Rightof Use Asset Cancellation
OperatingLeaseRightofUseAssetCancellation
100000 USD
hcsg Operating Lease Liability Cancellation
OperatingLeaseLiabilityCancellation
100000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2882000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4789000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3565000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1741000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1295000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1311000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4204000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19787000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
17500000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2200000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2083000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4165000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4165000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3169000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2035000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5092000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2035000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2618000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1700000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
800000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1100000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2200000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
6700000 USD
CY2019Q2 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
1600000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
1000000.0 USD
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
5000000.0 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
87226000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
92318000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
87016000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3695000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
90711000 USD
CY2019 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2498000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
876000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
33476000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
16071000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
20839000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
38801000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
35505000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
34963000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
92318000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
90711000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3925000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3659000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
20400000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2107000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
210000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
24.43
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
99000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
17.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
37.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
39000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
31.97
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2168000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.18
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
900000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1500000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.265
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.226
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.032
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.019
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1497000 USD
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1450000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
31.08
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1491000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
hcsg Sharebased Compensation Arrangementby Sharebased Payment Award Award Requisite Average Weekly Hoursof Work
SharebasedCompensationArrangementbySharebasedPaymentAwardAwardRequisiteAverageWeeklyHoursofWork
PT20H
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
30200000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20250
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20125
CY2020Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15128000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15033000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20375
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.19875
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40625
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39625
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
452029000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
462101000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
901179000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
938212000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
30412000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23617000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
57194000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
35509000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74695000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74352000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74676000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74327000 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
66000 shares
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
267000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
88000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
342000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74761000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74619000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74764000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74669000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2102000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1536000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2096000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1455000 shares
CY2020Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
475000000 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
10000000.0 USD
hcsg Lineof Credit Facility Increase Decrease Remaining Borrowing Capacity
LineofCreditFacilityIncreaseDecreaseRemainingBorrowingCapacity
-64900000 USD
CY2020Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
410100000 USD
CY2020Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
475000000 USD

Files In Submission

Name View Source Status
0000731012-20-000066-index-headers.html Edgar Link pending
0000731012-20-000066-index.html Edgar Link pending
0000731012-20-000066.txt Edgar Link pending
0000731012-20-000066-xbrl.zip Edgar Link pending
ceosection302certifica.htm Edgar Link pending
cfosection302certifica.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hcsg-20200630.htm Edgar Link pending
hcsg-20200630.xsd Edgar Link pending
hcsg-20200630_cal.xml Edgar Link unprocessable
hcsg-20200630_def.xml Edgar Link unprocessable
hcsg-20200630_htm.xml Edgar Link completed
hcsg-20200630_lab.xml Edgar Link unprocessable
hcsg-20200630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
section906certificatio.htm Edgar Link pending
Show.js Edgar Link pending